![]() |
|
|
Vol. 286, Issue 1, 115-121, July 1998
Department of Pharmacology and Experimental Therapeutics, Kyoto
Pharmaceutical University, Kyoto, Japan
The effects of a nitric oxide (NO)-releasing derivative of aspirin,
NCX-4016, on gastric functional and ulcerogenic responses in rat
stomachs were examined in comparison with those of aspirin. Topical
application of aspirin (80 mM) to the stomach markedly decreased
transmucosal potential difference and slightly increased luminal pH
(acid back-diffusion) with minimal effect on mucosal blood flow,
whereas NCX-4016 caused a marked increase in mucosal blood flow with no
effect on potential difference and pH. Aspirin itself was ulcerogenic,
causing damage in the mucosa when administered p.o., and it markedly
potentiated gastric ulcerogenic response to hypothermic stress
(28°C-30°C) with no effect on acid secretion when given s.c.
NCX-4016, however, was not ulcerogenic by itself, did not modify the
ulcerogenic response to stress and even showed a dose-dependent
protection against HCl/ethanol-induced gastric lesions. When NCX-4016
was given intragastrically to pylorus-ligated rats, a large amount of
NO was detected in both gastric contents and serum. NCX-4016
administered either p.o. or s.c. produced an equipotent inhibition of
mucosal PGE2 generation in the stomach, as compared with
aspirin. In addition, both aspirin and NCX-4016 suppressed
carrageenan-induced rat paw edema. These results suggest that, unlike
aspirin, the NO-releasing derivative of aspirin NCX-4016 neither had a
topical irritating action on the stomach nor exerted a worsening effect
on gastric ulcerogenic response to stress, but rather provided gastric
protection against ethanol, despite inhibiting cyclo-oxygenase activity
and showing anti-inflammatory action much as aspirin does. NCX-4016,
probably by releasing NO, exerted protective effects that counteracted
the potential damaging effects of cyclo-oxygenase inhibition.